The AchE inhibitor donepezil exerts neuroprotective effects by upregulating CREB (via MT/ERK/CREB signaling) phosphorylation levels in the hippocampus, thereby mitigating memory deficits triggered by transient cerebral ischemia [80]. This evidence concerns the gene CREB1 and transient ischemic attack.